Skip to Main Content

WASHINGTON — In the photo, the two men are grinning widely: the CEO of WuXi Biologics and the incoming CEO of the biotechnology industry’s largest trade group.

The photo, posted to WuXi’s LinkedIn page, shows the pair in a firm, congratulatory glad hand over John Crowley’s appointment to lead the Biotechnology Innovation Organization.

advertisement

Three months later, in March, sister company WuXi AppTec and BIO had ended their relationship, and Crowley was openly professing his support for legislation that would all but ban many U.S. biotechs from doing business with the Chinese behemoth.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.